Serum Cryoglobulin and Chronic Hepatitis C Virus Disease among Japanese Patients

The American Journal of Gastroenterology

Volumn 90, Issue 10, 1995, Pages 1847-1852

  Tanaka, Kazuma ^a,b   Aiyama, Toshiyuki ^a,b   Imai, Junko ^a,b   Morishita, Yoshitaka ^a,b   Fukatsu, Toshiaki ^a,b   Kakumu, Shinichi ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; COMPLEMENT HEMOLYSIS TEST; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS DETECTION;

ADULT; AGED; CARRIER STATE; CHRONIC DISEASE; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMAN; INTERFERON-ALPHA; JAPAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T;

EID: 0029023107     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1995.tb08084.x     Document Type: Article

References (29)

1. Isolation of a cDNA derived from a blood borne non‐A. non‐B viral hepatitis genome
2. An assay for circulating antibodies to a major cliologic virus of human non‐A. non‐13 hepatitis
3. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
4. Interrelationship of blood transfusion. non‐A
5. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprolein variants: Potential role in chronic HCV infections
6. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo
7. Equilibrium centrifugalion studies of hepatitis C virus: Evidence for circulating immune complexes
8. Neulralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses
9. Hepalitis C virus infection in patients with essential mixed cryonlobulinemia
10. Hepatitis C virus and mixed cryoglobulinemia
11. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
12. Hepatitis C: A possible etiology for cryoglobulinemia type II
13. A role for hepatitis C virus infection in type M cryoglohulinemia
14. Cryoglohulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
15. Interferon alfa‐2a therapy in cryoglohulinemia associated with hepatitis C virus
16. Mixed cryoglobulinemia and hepatitis C virus
17. High prevalence of hepatitis C virus RN A in the supernatant and the cryopreeipitate of patients with essential and secondary type II mixed cryoglobulinemia
18. Biologic and clinical significance of cryoglobulins: A report of 86 cases
19. Characterization of cryoglobulins by immunoblotting
20. Defection of hepatitis C virus by potymerase chain reaction and response to interleron‐α therapy: Relationship lo genotypes of hepatitis C virus
21. Acute and chronic hepatitis revisited
22. The cold activation of the classical complement pathway. The cause of the differences between plasma and serum complement in liver cirrhosis
23. Cold‐dependent activation of complement: Recognition, assessment, and mechanism
24. Typing hepatitis C virus by polymerase chain reaction with type‐specific primers; Application to clinical surveys and tracing infectious sources
25. Sequence variability in the 5′ non‐coding region of hepatitis C virus: Identification of a new virus type and restriction on sequence diversity
26. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses
27. Association between hepatitis B virus and essential mixed cryoglohulinemia
28. Essential mixed cryoglohulinemia without evidence for hepatitis B virus infection
29. Hepatitis B virus markers in monoclonal (type I and II) and potyclonal (type III) cryoglobulinemia